Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2020

01-02-2020 | Concise Research Reports

Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study

Authors: Andrea Banuelos Mota, BA, Emilio Ernesto Feliz Sala, BA, Jennifer M. Perdomo, BS, Joel Alejandro Solis, BA, Walter M. Solorzano, BA, Michael Hochman, MD, MPH, Jo Marie Reilly, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2020

Login to get access

Excerpt

Latino adults have higher diabetes rates (12.8%) than non-Latinos (7.6%) and are more likely to have suboptimal glycemic control.1 Medication adherence can impact morbidity and mortality from diabetes.2 Prior research demonstrates that improving medication adherence among patients with chronic diseases is challenging and that Latino populations may be less adherent to medications than non-Latinos.1, 3 One study found that 37% of Latinos had high scores on Morisky Medication Adherence Scale versus 50% of non-Latinos, indicating poorer adherence among Latinos.4
Appendix
Available only for authorised users
Literature
3.
go back to reference Polonsky W, Henry R. Poor medication adherence in type II diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016; 10: 1299–1307.CrossRef Polonsky W, Henry R. Poor medication adherence in type II diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016; 10: 1299–1307.CrossRef
4.
go back to reference Lopez JM, Bailey RA, Rupnow MF, et al. Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey. Clin Ther. 2014;36:494–506.CrossRef Lopez JM, Bailey RA, Rupnow MF, et al. Characterization of type 2 diabetes mellitus burden by age and ethnic groups based on a nationwide survey. Clin Ther. 2014;36:494–506.CrossRef
Metadata
Title
Assessing Barriers to Medication Adherence Among Latinos with Diabetes: a Cross-sectional Study
Authors
Andrea Banuelos Mota, BA
Emilio Ernesto Feliz Sala, BA
Jennifer M. Perdomo, BS
Joel Alejandro Solis, BA
Walter M. Solorzano, BA
Michael Hochman, MD, MPH
Jo Marie Reilly, MD, MPH
Publication date
01-02-2020
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05041-3

Other articles of this Issue 2/2020

Journal of General Internal Medicine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.